Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
妇舒颗粒治疗湿热蕴结型盆腔炎性疾病后遗症慢性盆腔痛临床安全性有效性随机双盲安慰剂对照、多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial on the safety and efficacy of Fushu Granules in the treatment of chronic pelvic pain caused by sequelae of pelvic inflammatory disease with damp-heat accumulation
评价妇舒颗粒治疗(湿热蕴结型)盆腔炎性疾病后遗症(慢性盆腔痛)的有效性和安全性
[Translation] To evaluate the efficacy and safety of Fushu Granule in the treatment of sequelae (chronic pelvic pain) of pelvic inflammatory disease (damp-heat accumulation type)
妇舒颗粒治疗湿热蕴结型盆腔炎性疾病后遗症慢性盆腔痛临床安全性有效性随机双盲安慰剂对照多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial on the safety and efficacy of Fushu Granules in the treatment of chronic pelvic pain caused by sequelae of pelvic inflammatory disease of damp-heat accumulation type
评价妇舒颗粒治疗(湿热蕴结型)盆腔炎性疾病后遗症(慢性盆腔痛)的有效性和安全性
[Translation] To evaluate the efficacy and safety of Fushu Granule in the treatment of sequelae (chronic pelvic pain) of pelvic inflammatory disease (damp-heat accumulation type)
100 Clinical Results associated with Hefei Cornerstone Pharmaceutical Development Co., Ltd.
0 Patents (Medical) associated with Hefei Cornerstone Pharmaceutical Development Co., Ltd.
100 Deals associated with Hefei Cornerstone Pharmaceutical Development Co., Ltd.
100 Translational Medicine associated with Hefei Cornerstone Pharmaceutical Development Co., Ltd.